NCT06785454Phase 2Completed

A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension

Study sponsor: Mineralys Therapeutics Inc. · MLYS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-12-17Actual
Enrollment · participants48Actual
Source updated2026-08-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Dec 2025. After: 17 Dec 2025.

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview